Operating Cash Flow CAGR:-5.02%(TTM)
Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
Over longer horizons, Operating Cash Flow CAGR averages -23.53% over 3 years and 6.20% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Operating cash flow CAGR measures the compound annual growth rate of the cash Albemarle Corporation generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history.
ALB Operating Cash Flow CAGR Chart
Albemarle Corporation (ALB)
ALB Quarterly Operating Cash Flow Growth (YoY)
Operating Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
ALB Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $687.88M | $1.28B | +$594.39M | +86.41% | +86.41% |
| 2024 | $1.33B | $687.88M | $-638.71M | -48.15% | -48.15% |
| 2023 | $1.91B | $1.33B | $-581.27M | -30.47% | -30.47% |
| 2022 | $344.26M | $1.91B | +$1.56B | +454.19% | +454.19% |
| 2021 | $798.91M | $344.26M | $-454.66M | -56.91% | -56.91% |
| 2020 | $719.37M | $798.91M | +$79.54M | +11.06% | +11.06% |
| 2019 | $546.16M | $719.37M | +$173.21M | +31.71% | +31.71% |
| 2018 | $303.98M | $546.16M | +$242.19M | +79.67% | +79.67% |
| 2017 | $733.40M | $303.98M | $-429.42M | -58.55% | -58.55% |
| 2016 | $360.69M | $733.40M | +$372.71M | +103.33% | +103.33% |
| 2015 | $492.61M | $360.69M | $-131.92M | -26.78% | -26.78% |
| 2014 | $432.86M | $492.61M | +$59.75M | +13.80% | +13.80% |
| 2013 | $488.77M | $432.86M | $-55.91M | -11.44% | -11.44% |
| 2012 | $457.59M | $488.77M | +$31.18M | +6.81% | +6.81% |
| 2011 | $331.31M | $457.59M | +$126.28M | +38.12% | +38.12% |
| 2010 | $358.52M | $331.31M | $-27.22M | -7.59% | -7.59% |
| 2009 | $315.75M | $358.52M | +$42.78M | +13.55% | +13.55% |
| 2008 | $242.54M | $315.75M | +$73.20M | +30.18% | +30.18% |
| 2007 | $376.29M | $242.54M | $-133.75M | -35.54% | -35.54% |
| 2006 | $168.86M | $376.29M | +$207.43M | +122.84% | +122.84% |
| 2005 | $191.56M | $168.86M | $-22.69M | -11.85% | -11.85% |
| 2004 | $150.10M | $191.56M | +$41.46M | +27.62% | +27.62% |
| 2003 | $144.77M | $150.10M | +$5.33M | +3.68% | +3.68% |
| 2002 | $143.97M | $144.77M | +$806.00K | +0.56% | +0.56% |
| 2001 | $155.07M | $143.97M | $-11.10M | -7.16% | -7.16% |
| 2000 | $164.30M | $155.07M | $-9.23M | -5.62% | -5.62% |
| 1999 | $137.21M | $164.30M | +$27.08M | +19.74% | +19.74% |
| 1998 | $98.81M | $137.21M | +$38.41M | +38.87% | +38.87% |
| 1997 | $28.47M | $98.81M | +$70.34M | +247.07% | +247.07% |
Quarterly Operating Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $346.24M | -10.9% | -36.5% |
| Q4 2025 | $388.49M | +9.2% | — |
| Q3 2025 | $355.60M | — | +56.6% |
| Q2 2025 | -$7.20M | — | — |
| Q1 2025 | $545.38M | — | +456.8% |
| Q4 2024 | $674,000 | -99.7% | — |
| Q3 2024 | $227.11M | -38.2% | -63.9% |
| Q2 2024 | $367.19M | +274.9% | +398.2% |
| Q1 2024 | $97.95M | — | -86.4% |
| Q4 2023 | -$98.22M | — | — |
| Q3 2023 | $628.85M | +753.2% | -29.8% |
| Q2 2023 | $73.71M | -89.8% | — |
| Q1 2023 | $720.98M | -24.3% | +249.7% |
| Q4 2022 | $952.25M | +6.4% | — |
| Q3 2022 | $895.29M | — | +754.8% |
| Q2 2022 | -$145.87M | — | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Albemarle Corporation
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Jerry Kent Jr.